AI-Driven Assessment of The Efficacy And Safety of Gene and Cell-Based Therapies for Ischemic Heart Disease: A Systematic Review of Clinical Trials. JOC 2024, 23 (1), 1065-1078. https://doi.org/10.66838/J.Carcinog.23.1.1065-1078.